US Stock MarketDetailed Quotes
LIFE aTyr Pharma
- 1.640
- 0.0000.00%
Trading Apr 23 15:26 ET
111.42MMarket Cap-1744P/E (TTM)
1.690High1.620Low187.14KVolume1.690Open1.640Pre Close307.92KTurnover0.31%Turnover RatioLossP/E (Static)67.94MShares2.70052wk High1.23P/B98.87MFloat Cap1.08052wk Low--Dividend TTM60.29MShs Float396.060Historical High--Div YieldTTM4.27%Amplitude1.080Historical Low1.645Avg Price1Lot Size
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
aTyr Pharma Stock Forum
🚀
Fcking genius alert is better than paid discords 🤑🤑🤑🚀🚀🚀 alerted bottoms 1.07
Load this shit up next month gonna be massive squeeze
Management highlighted plans to launch the ATYR1923 PH3 trial in pulmonary sarcoidosis in 2022. The company will also present additional preclinical data from ATYR2810 at SITC 2021 tomorrow and plans to move ATYR2810 into clinical trials next year. Recent attention has focused on the ph3 trial design conducted after the company's meeting with the FDA.
Hold or sell
I bought at 9.8 .last 2 weeks it is hovering around 9 .any chance of break even?
Following successful completion of PH2, aTyr plans to hold a meeting with FDA to discuss the PH3 study design as soon as possible, and data release is in the works. The company recently announced a collaboration with Ohio State University to develop a companion diagnosis as a predictive biomarker for granuloma formation to identify better responders to ATRY1923 in pulmonary sarcoidosis.
Stocks with no short shares available and high interest
No comment yet